+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
NGAL ELISA Kit Market by End-User (Academic Research, Hospital & Diagnostic Centers, Pharmaceutical & Biotechnology Companies), Assay Type (Competitive Elisa, Sandwich Elisa), Application, Kit Format, Detection Method, Distribution Channel - Global Forecast 2025-2030- Product Image
NGAL ELISA Kit Market by End-User (Academic Research, Hospital & Diagnostic Centers, Pharmaceutical & Biotechnology Companies), Assay Type (Competitive Elisa, Sandwich Elisa), Application, Kit Format, Detection Method, Distribution Channel - Global Forecast 2025-2030- Product Image
New

NGAL ELISA Kit Market by End-User (Academic Research, Hospital & Diagnostic Centers, Pharmaceutical & Biotechnology Companies), Assay Type (Competitive Elisa, Sandwich Elisa), Application, Kit Format, Detection Method, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 184 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6137559
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
Neutrophil gelatinase-associated lipocalin, commonly referred to as NGAL, has emerged as a pivotal biomarker in the early detection of acute kidney injury, as well as in tracking inflammatory responses and cardiovascular events. Over the past decade, the advent of ELISA kits tailored to NGAL quantification has transformedboth clinical diagnostics and academic research by offering high sensitivity and specificity in protein measurement. These immunoassays have become indispensable tools for laboratories seeking rapid, reliable, and reproducible results in complex biological matrices.

In clinical settings, NGAL ELISA kits enable practitioners to identify renal compromise within hours of insult, far earlier than traditional markers such as serum creatinine. Parallel developments in research institutes and pharmaceutical development have leveraged NGAL assays to elucidate molecular pathways in oncology, inflammatory diseases, and organ transplantation. Consequently, NGAL ELISA technology sits at the intersection of patient care and translational science, driving new diagnostic paradigms and therapeutic approaches. As stakeholders explore this dynamic landscape, understanding the foundational role of NGAL detection lays the groundwork for strategic decision making and innovation.

Exploring the Technological Innovations and Market Dynamics Shaping the Evolution of NGAL ELISA Solutions in Clinical Diagnostics and Research

Recent years have witnessed remarkable technological breakthroughs that are reshaping the capabilities of NGAL ELISA solutions. Automated platforms now integrate microplate handling, incubation, and optical detection in unified workflows, reducing manual intervention and minimizing variability. In parallel, the shift toward multiplexed immunoassay systems is facilitating simultaneous detection of NGAL alongside complementary biomarkers, thereby enhancing diagnostic accuracy and resource efficiency in high-throughput environments.

Assay format innovations, including next-generation sandwich and competitive ELISA designs, are delivering lower limits of detection and broader dynamic ranges to accommodate both research and point-of-care contexts. Moreover, the adoption of advanced detection modalities such as chemiluminescent and fluorescent readouts has accelerated turnaround times while improving signal-to-noise ratios. These developments are further supported by digital integration tools that enable real-time data analytics and secure cloud-based result sharing. Collectively, these market dynamics underscore a transformation toward more robust, scalable, and interconnected NGAL ELISA offerings.

Analyzing the Implications of 2025 United States Tariffs on NGAL ELISA Kit Supply Chains and Global Reagent Sourcing Strategies

The implementation of new United States tariff measures in 2025 has introduced significant considerations for organizations sourcing NGAL ELISA components and reagents. As import duties on critical assay materials rose, supply chain stakeholders have felt pressure to reassess vendor relationships and procurement strategies. In response, many kit providers have accelerated efforts to localize manufacturing or to partner with domestic suppliers in order to mitigate cost fluctuations and lead-time uncertainties.

Consequently, laboratory managers and procurement officers are increasingly conducting comprehensive risk assessments, balancing the benefits of established international suppliers against emerging local manufacturing opportunities. At the same time, regulatory compliance remains a central concern, as changes in trade policy intersect with quality standards and export controls. Although these tariff adjustments present challenges for cost management, they also drive investment in resilient supply chains and foster deeper collaboration between end-users and assay developers.

Delving into End-User, Assay Type, Application, Kit Format, Detection Method and Distribution Channel Segmentation to Inform Targeting in NGAL ELISA Markets

An end-user examination reveals that academic research organizations, spanning research institutes and universities, place a premium on assay reproducibility and data comparability for longitudinal studies. Hospital and diagnostic centers, including both private and public institutions, prioritize throughput and ease of integration into existing laboratory information systems. Pharmaceutical and biotechnology companies, from agile startups to established global firms, demand stringent quality controls and scalable formats to support preclinical screening and clinical trial applications.

Assay type insights distinguish the competitive ELISA format, valued for rapid screening and minimal sample preparation, from the sandwich ELISA approach, which offers enhanced specificity and quantification across low-concentration analytes. Application segmentation highlights oncology research initiatives probing NGAL’s role in tumor progression, cardiology studies assessing post-ischemic injury, inflammatory disease investigations mapping cytokine interactions, and clinical diagnostics focusing on early kidney injury detection. Kit format preferences divide along the lines of automated ELISA systems that accommodate high volumes with minimal hands-on time, versus manual ELISA setups that enable customized workflows in resource-constrained settings.

Detection method segmentation underscores a growing shift toward chemiluminescent assays, which deliver superior sensitivity, alongside colorimetric options favored for cost efficiency and fluorescent platforms that support multiplex analysis. Finally, distribution channel insights illustrate the dual importance of direct sales-facilitated by field representatives and third-party distributors-for personalized technical support, alongside online access via company websites and leading e-commerce platforms for rapid procurement and transparent pricing.

Uncovering Regional Variations in NGAL ELISA Adoption Across the Americas, Europe Middle East Africa, and Asia-Pacific to Guide Strategic Investments

Regional adoption of NGAL ELISA technologies reflects a diverse set of healthcare infrastructures and research priorities. In the Americas, robust clinical trial networks and well-established diagnostic laboratories have driven widespread uptake of NGAL assays, supported by comprehensive reimbursement frameworks and proactive regulatory pathways. The presence of major assay manufacturers in North America has further bolstered local availability and technical support networks.

In Europe, Middle East and Africa, variable market maturity levels coexist, with leading European laboratories integrating automated NGAL ELISA platforms while emerging markets in the Middle East invest in foundational diagnostic capabilities. In these territories, ongoing efforts to harmonize regulatory standards and enhance local research capacity are critical for sustained penetration. Partnerships between academic centers and industry players are fostering knowledge transfer, particularly in regions prioritizing kidney disease screening programs.

The Asia-Pacific region exhibits rapid growth driven by expanding research funding, rising prevalence of chronic kidney disease, and government initiatives targeting early diagnostic solutions. Local manufacturing hubs in key markets have contributed to competitive pricing and broader access, while distribution partnerships across direct and online channels ensure that laboratories of all sizes can implement NGAL assays effectively. This geographic diversity underscores the need for tailored market entry strategies and region-specific support models.

Profiling Leading NGAL ELISA Kit Manufacturers and Innovators to Understand Competitive Strengths, Partnerships, and Product Differentiation

Leading manufacturers in the NGAL ELISA arena distinguish themselves through a combination of stringent quality management systems, innovative assay chemistry, and comprehensive technical support services. Several established life science companies have expanded their immunoassay portfolios to include NGAL kits, leveraging global distribution networks and long-standing partnerships with diagnostic laboratories. In parallel, emerging specialty firms are introducing next-generation chemistries and streamlined workflows tailored to point-of-care applications.

Collaborations between assay developers and academic institutions have accelerated reagent optimization, resulting in enhanced antibody specificity and improved lot-to-lot consistency. Moreover, joint ventures between biotechnology firms and contract research organizations enable rapid validation of NGAL assays in diverse sample matrices, including serum, plasma, and urine. Strategic alliances with platform providers have facilitated seamless integration of NGAL ELISA kits into automated analyzers and digital reporting systems. These competitive dynamics emphasize the importance of product differentiation, regional presence, and post-sales support in securing long-term customer relationships.

Strategic Actions Healthcare and Research Leadership Can Implement to Optimize NGAL ELISA Integration, Enhance Collaboration and Drive Clinical Impact

Healthcare and research leaders seeking to maximize the impact of NGAL ELISA technologies should prioritize integrated collaboration between clinical teams, laboratory scientists, and procurement functions. Establishing cross-functional task forces can drive standardized protocols that align assay selection with specific diagnostic or research objectives. Additionally, investing in training programs that emphasize assay design principles, data interpretation, and troubleshooting best practices will expedite adoption and minimize variability.

Organizations can further enhance operational efficiency by evaluating modular automation platforms that accommodate both high-throughput screening and custom research projects. Collaborations with equipment vendors to co-develop tailored workflows will streamline sample handling and data management. Engaging in early dialogue with regulatory authorities ensures clarity around validation requirements and supports expedited pathway approvals. Finally, fostering partnerships with academic centers and patient advocacy groups can inform clinical trial design and reinforce the clinical value proposition of NGAL assays, ultimately translating analytical performance into improved patient outcomes.

Outlining the Rigorous Data Collection, Analytical Techniques, and Validation Protocols Underpinning the Comprehensive NGAL ELISA Market Study

This analysis is grounded in a rigorous research framework combining primary and secondary data sources. Primary insights were gathered through structured interviews and surveys with key opinion leaders, including clinical laboratory directors, academic investigators, and procurement specialists. Secondary information was derived from peer-reviewed publications, regulatory agency databases, and publicly available technical specifications from assay manufacturers.

Analytical techniques included qualitative thematic analysis to identify emerging trends, PESTEL evaluation of regulatory and economic drivers, and competitive benchmarking to assess vendor capabilities. Validation protocols involved cross-referencing supplier claims with independent laboratory performance data and consulting external quality assessment programs. This multi-layered approach ensured the integrity and relevance of the findings, offering decision-makers a comprehensive perspective on NGAL ELISA technologies and market dynamics.

Summarizing Key Findings and Forward-Looking Perspectives to Empower Stakeholders Engaging with NGAL ELISA Technologies in Clinical and Research Settings

The evidence gathered underscores the expanding role of NGAL ELISA assays as essential tools for early detection of kidney injury, inflammatory disease research, and translational applications across oncology and cardiology. Technological innovations in automation, detection methods, and assay formats are driving improved sensitivity, throughput, and workflow integration. Simultaneously, evolving trade policies and tariff structures are reshaping supply chain strategies, prompting a move toward localized manufacturing and diversified procurement models.

Segmentation insights reveal distinct needs among academic, clinical, and industry end users, while regional perspectives highlight the importance of tailored market approaches across the Americas, Europe Middle East Africa, and Asia-Pacific. Competitive landscapes are defined by collaborations that enhance reagent quality, platform compatibility, and technical support. By synthesizing these findings, stakeholders are equipped with the context necessary to make informed decisions regarding NGAL ELISA implementation, research collaborations, and strategic investments moving forward.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • End-User
    • Academic Research
      • Research Institutes
      • Universities
    • Hospital & Diagnostic Centers
      • Private Hospitals
      • Public Hospitals
    • Pharmaceutical & Biotechnology Companies
      • Biotech Startups
      • Large Pharmaceutical Companies
  • Assay Type
    • Competitive Elisa
    • Sandwich Elisa
  • Application
    • Cancer Research
    • Cardiovascular Disease
    • Inflammatory Disease
    • Kidney Injury Diagnosis
  • Kit Format
    • Automated Elisa
    • Manual Elisa
  • Detection Method
    • Chemiluminescent
    • Colorimetric
    • Fluorescent
  • Distribution Channel
    • Direct Sales
      • Field Sales
      • Third-Party Distributors
    • Online
      • Company Website
      • E-Commerce Platforms
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Thermo Fisher Scientific, Inc.
  • Bio-Techne Corporation
  • Abcam plc
  • BioPorto Diagnostics A/S
  • BioVendor - Laboratorní medicína a.s.
  • RayBiotech, Inc.
  • Sino Biological Inc.
  • Aviva Systems Biology Corporation
  • Boster Biological Technology Co., Ltd.
  • BioVision, Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of NGAL ELISA assays into microfluidic point-of-care platforms for rapid acute kidney injury screening
5.2. Development of multiplexed biomarker panels combining NGAL with cystatin C and KIM-1 for early sepsis diagnosis
5.3. Adoption of high-sensitivity recombinant antibody technologies to enhance NGAL ELISA assay detection limits
5.4. Expansion of NGAL ELISA kit applications in neonatal intensive care units for early detection of pediatric kidney injury
5.5. Collaborations between diagnostic companies and academic centers to standardize NGAL measurement protocols for clinical practice
5.6. Regulatory approvals driving the commercialization of automated NGAL ELISA systems for hospital laboratory workflows
5.7. Cost optimization strategies using recombinant NGAL standards to reduce per-test expenses in large-scale kidney disease screening
5.8. Emerging use of NGAL ELISA testing in veterinary medicine for early monitoring of renal disorders in companion animals
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. NGAL ELISA Kit Market, by End-User
8.1. Introduction
8.2. Academic Research
8.2.1. Research Institutes
8.2.2. Universities
8.3. Hospital & Diagnostic Centers
8.3.1. Private Hospitals
8.3.2. Public Hospitals
8.4. Pharmaceutical & Biotechnology Companies
8.4.1. Biotech Startups
8.4.2. Large Pharmaceutical Companies
9. NGAL ELISA Kit Market, by Assay Type
9.1. Introduction
9.2. Competitive Elisa
9.3. Sandwich Elisa
10. NGAL ELISA Kit Market, by Application
10.1. Introduction
10.2. Cancer Research
10.3. Cardiovascular Disease
10.4. Inflammatory Disease
10.5. Kidney Injury Diagnosis
11. NGAL ELISA Kit Market, by Kit Format
11.1. Introduction
11.2. Automated Elisa
11.3. Manual Elisa
12. NGAL ELISA Kit Market, by Detection Method
12.1. Introduction
12.2. Chemiluminescent
12.3. Colorimetric
12.4. Fluorescent
13. NGAL ELISA Kit Market, by Distribution Channel
13.1. Introduction
13.2. Direct Sales
13.2.1. Field Sales
13.2.2. Third-Party Distributors
13.3. Online
13.3.1. Company Website
13.3.2. E-Commerce Platforms
14. Americas NGAL ELISA Kit Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa NGAL ELISA Kit Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific NGAL ELISA Kit Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Thermo Fisher Scientific, Inc.
17.3.2. Bio-Techne Corporation
17.3.3. Abcam plc
17.3.4. BioPorto Diagnostics A/S
17.3.5. BioVendor - Laboratorní medicína a.s.
17.3.6. RayBiotech, Inc.
17.3.7. Sino Biological Inc.
17.3.8. Aviva Systems Biology Corporation
17.3.9. Boster Biological Technology Co., Ltd.
17.3.10. BioVision, Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. NGAL ELISA KIT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL NGAL ELISA KIT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL NGAL ELISA KIT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL NGAL ELISA KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NGAL ELISA KIT MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 6. GLOBAL NGAL ELISA KIT MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NGAL ELISA KIT MARKET SIZE, BY ASSAY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NGAL ELISA KIT MARKET SIZE, BY ASSAY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NGAL ELISA KIT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NGAL ELISA KIT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL NGAL ELISA KIT MARKET SIZE, BY DETECTION METHOD, 2024 VS 2030 (%)
FIGURE 14. GLOBAL NGAL ELISA KIT MARKET SIZE, BY DETECTION METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS NGAL ELISA KIT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS NGAL ELISA KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES NGAL ELISA KIT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES NGAL ELISA KIT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NGAL ELISA KIT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA NGAL ELISA KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC NGAL ELISA KIT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC NGAL ELISA KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. NGAL ELISA KIT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. NGAL ELISA KIT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. NGAL ELISA KIT MARKET: RESEARCHAI
FIGURE 28. NGAL ELISA KIT MARKET: RESEARCHSTATISTICS
FIGURE 29. NGAL ELISA KIT MARKET: RESEARCHCONTACTS
FIGURE 30. NGAL ELISA KIT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. NGAL ELISA KIT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NGAL ELISA KIT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL NGAL ELISA KIT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL NGAL ELISA KIT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL NGAL ELISA KIT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL NGAL ELISA KIT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL NGAL ELISA KIT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL NGAL ELISA KIT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL NGAL ELISA KIT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL NGAL ELISA KIT MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL NGAL ELISA KIT MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL NGAL ELISA KIT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL NGAL ELISA KIT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL NGAL ELISA KIT MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL NGAL ELISA KIT MARKET SIZE, BY UNIVERSITIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL NGAL ELISA KIT MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL NGAL ELISA KIT MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL NGAL ELISA KIT MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL NGAL ELISA KIT MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL NGAL ELISA KIT MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL NGAL ELISA KIT MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL NGAL ELISA KIT MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL NGAL ELISA KIT MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL NGAL ELISA KIT MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL NGAL ELISA KIT MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL NGAL ELISA KIT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL NGAL ELISA KIT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL NGAL ELISA KIT MARKET SIZE, BY BIOTECH STARTUPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL NGAL ELISA KIT MARKET SIZE, BY BIOTECH STARTUPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL NGAL ELISA KIT MARKET SIZE, BY LARGE PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL NGAL ELISA KIT MARKET SIZE, BY LARGE PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL NGAL ELISA KIT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL NGAL ELISA KIT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL NGAL ELISA KIT MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL NGAL ELISA KIT MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL NGAL ELISA KIT MARKET SIZE, BY COMPETITIVE ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL NGAL ELISA KIT MARKET SIZE, BY COMPETITIVE ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL NGAL ELISA KIT MARKET SIZE, BY SANDWICH ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL NGAL ELISA KIT MARKET SIZE, BY SANDWICH ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL NGAL ELISA KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL NGAL ELISA KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL NGAL ELISA KIT MARKET SIZE, BY CANCER RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL NGAL ELISA KIT MARKET SIZE, BY CANCER RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL NGAL ELISA KIT MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL NGAL ELISA KIT MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL NGAL ELISA KIT MARKET SIZE, BY INFLAMMATORY DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL NGAL ELISA KIT MARKET SIZE, BY INFLAMMATORY DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL NGAL ELISA KIT MARKET SIZE, BY KIDNEY INJURY DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL NGAL ELISA KIT MARKET SIZE, BY KIDNEY INJURY DIAGNOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL NGAL ELISA KIT MARKET SIZE, BY AUTOMATED ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL NGAL ELISA KIT MARKET SIZE, BY AUTOMATED ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL NGAL ELISA KIT MARKET SIZE, BY MANUAL ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL NGAL ELISA KIT MARKET SIZE, BY MANUAL ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL NGAL ELISA KIT MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL NGAL ELISA KIT MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL NGAL ELISA KIT MARKET SIZE, BY CHEMILUMINESCENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL NGAL ELISA KIT MARKET SIZE, BY CHEMILUMINESCENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL NGAL ELISA KIT MARKET SIZE, BY COLORIMETRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL NGAL ELISA KIT MARKET SIZE, BY COLORIMETRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL NGAL ELISA KIT MARKET SIZE, BY FLUORESCENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL NGAL ELISA KIT MARKET SIZE, BY FLUORESCENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL NGAL ELISA KIT MARKET SIZE, BY FIELD SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL NGAL ELISA KIT MARKET SIZE, BY FIELD SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL NGAL ELISA KIT MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL NGAL ELISA KIT MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL NGAL ELISA KIT MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL NGAL ELISA KIT MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL NGAL ELISA KIT MARKET SIZE, BY COMPANY WEBSITE, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL NGAL ELISA KIT MARKET SIZE, BY COMPANY WEBSITE, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL NGAL ELISA KIT MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL NGAL ELISA KIT MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL NGAL ELISA KIT MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL NGAL ELISA KIT MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS NGAL ELISA KIT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS NGAL ELISA KIT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS NGAL ELISA KIT MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS NGAL ELISA KIT MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS NGAL ELISA KIT MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS NGAL ELISA KIT MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS NGAL ELISA KIT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS NGAL ELISA KIT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS NGAL ELISA KIT MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS NGAL ELISA KIT MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS NGAL ELISA KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS NGAL ELISA KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS NGAL ELISA KIT MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS NGAL ELISA KIT MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS NGAL ELISA KIT MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS NGAL ELISA KIT MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS NGAL ELISA KIT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS NGAL ELISA KIT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES NGAL ELISA KIT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES NGAL ELISA KIT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES NGAL ELISA KIT MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES NGAL ELISA KIT MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES NGAL ELISA KIT MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES NGAL ELISA KIT MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES NGAL ELISA KIT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES NGAL ELISA KIT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES NGAL ELISA KIT MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES NGAL ELISA KIT MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES NGAL ELISA KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES NGAL ELISA KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES NGAL ELISA KIT MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES NGAL ELISA KIT MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES NGAL ELISA KIT MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES NGAL ELISA KIT MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES NGAL ELISA KIT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES NGAL ELISA KIT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 131. CANADA NGAL ELISA KIT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 132. CANADA NGAL ELISA KIT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 133. CANADA NGAL ELISA KIT MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 134. CANADA NGAL ELISA KIT MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 135. CANADA NGAL ELISA KIT MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 136. CANADA NGAL ELISA KIT MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 137. CANADA NGAL ELISA KIT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 138. CANADA NGAL ELISA KIT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 139. CANADA NGAL ELISA KIT MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 140. CANADA NGAL ELISA KIT MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 141. CANADA NGAL ELISA KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 142. CANADA NGAL ELISA KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 143. CANADA NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2018-2024 (USD MILLION)
TABLE 144. CANADA NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2025-2030 (USD MILLION)
TABLE 145. CANADA NGAL ELISA KIT MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 146. CANADA NGAL ELISA KIT MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 147. CANADA NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. CANADA NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. CANADA NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 150. CANADA NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 151. CANADA NGAL ELISA KIT MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 152. CANADA NGAL ELISA KIT MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 153. MEXICO NGAL ELISA KIT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 154. MEXICO NGAL ELISA KIT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 155. MEXICO NGAL ELISA KIT MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 156. MEXICO NGAL ELISA KIT MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 157. MEXICO NGAL ELISA KIT MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 158. MEXICO NGAL ELISA KIT MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 159. MEXICO NGAL ELISA KIT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 160. MEXICO NGAL ELISA KIT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 161. MEXICO NGAL ELISA KIT MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 162. MEXICO NGAL ELISA KIT MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 163. MEXICO NGAL ELISA KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 164. MEXICO NGAL ELISA KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 165. MEXICO NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2018-2024 (USD MILLION)
TABLE 166. MEXICO NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2025-2030 (USD MILLION)
TABLE 167. MEXICO NGAL ELISA KIT MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 168. MEXICO NGAL ELISA KIT MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 169. MEXICO NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. MEXICO NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. MEXICO NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 172. MEXICO NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 173. MEXICO NGAL ELISA KIT MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 174. MEXICO NGAL ELISA KIT MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL NGAL ELISA KIT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL NGAL ELISA KIT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL NGAL ELISA KIT MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL NGAL ELISA KIT MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL NGAL ELISA KIT MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL NGAL ELISA KIT MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL NGAL ELISA KIT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL NGAL ELISA KIT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL NGAL ELISA KIT MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL NGAL ELISA KIT MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL NGAL ELISA KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL NGAL ELISA KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL NGAL ELISA KIT MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL NGAL ELISA KIT MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL NGAL ELISA KIT MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL NGAL ELISA KIT MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA NGAL ELISA KIT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA NGAL ELISA KIT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA NGAL ELISA KIT MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA NGAL ELISA KIT MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA NGAL ELISA KIT MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA NGAL ELISA KIT MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA NGAL ELISA KIT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA NGAL ELISA KIT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA NGAL ELISA KIT MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA NGAL ELISA KIT MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA NGAL ELISA KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA NGAL ELISA KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA NGAL ELISA KIT MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA NGAL ELISA KIT MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA NGAL ELISA KIT MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA NGAL ELISA KIT MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA NGAL ELISA KIT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA NGAL ELISA KIT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA NGAL ELISA KIT MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA NGAL ELISA KIT MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA NGAL ELISA KIT MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA NGAL ELISA KIT MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA NGAL ELISA KIT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA NGAL ELISA KIT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA NGAL ELISA KIT MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA NGAL ELISA KIT MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA NGAL ELISA KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA NGAL ELISA KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA NGAL ELISA KIT MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA NGAL ELISA KIT MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA NGAL ELISA KIT MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA NGAL ELISA KIT MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA NGAL ELISA KIT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA NGAL ELISA KIT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM NGAL ELISA KIT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM NGAL ELISA KIT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM NGAL ELISA KIT MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM NGAL ELISA KIT MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM NGAL ELISA KIT MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM NGAL ELISA KIT MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM NGAL ELISA KIT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM NGAL ELISA KIT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM NGAL ELISA KIT MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM NGAL ELISA KIT MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM NGAL ELISA KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM NGAL ELISA KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM NGAL ELISA KIT MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM NGAL ELISA KIT MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM NGAL ELISA KIT MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM NGAL ELISA KIT MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 265. GERMANY NGAL ELISA KIT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 266. GERMANY NGAL ELISA KIT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 267. GERMANY NGAL ELISA KIT MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 268. GERMANY NGAL ELISA KIT MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 269. GERMANY NGAL ELISA KIT MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 270. GERMANY NGAL ELISA KIT MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 271. GERMANY NGAL ELISA KIT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 272. GERMANY NGAL ELISA KIT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 273. GERMANY NGAL ELISA KIT MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 274. GERMANY NGAL ELISA KIT MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 275. GERMANY NGAL ELISA KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 276. GERMANY NGAL ELISA KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 277. GERMANY NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2018-2024 (USD MILLION)
TABLE 278. GERMANY NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2025-2030 (USD MILLION)
TABLE 279. GERMANY NGAL ELISA KIT MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 280. GERMANY NGAL ELISA KIT MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 281. GERMANY NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 282. GERMANY NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 283. GERMANY NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 284. GERMANY NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 285. GERMANY NGAL ELISA KIT MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 286. GERMANY NGAL ELISA KIT MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 287. FRANCE NGAL ELISA KIT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 288. FRANCE NGAL ELISA KIT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 289. FRANCE NGAL ELISA KIT MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 290. FRANCE NGAL ELISA KIT MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 291. FRANCE NGAL ELISA KIT MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 292. FRANCE NGAL ELISA KIT MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 293. FRANCE NGAL ELISA KIT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 294. FRANCE NGAL ELISA KIT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 295. FRANCE NGAL ELISA KIT MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 296. FRANCE NGAL ELISA KIT MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 297. FRANCE NGAL ELISA KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 298. FRANCE NGAL ELISA KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 299. FRANCE NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2018-2024 (USD MILLION)
TABLE 300. FRANCE NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2025-2030 (USD MILLION)
TABLE 301. FRANCE NGAL ELISA KIT MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 302. FRANCE NGAL ELISA KIT MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 303. FRANCE NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 304. FRANCE NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 305. FRANCE NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 306. FRANCE NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 307. FRANCE NGAL ELISA KIT MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 308. FRANCE NGAL ELISA KIT MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 309. RUSSIA NGAL ELISA KIT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 310. RUSSIA NGAL ELISA KIT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 311. RUSSIA NGAL ELISA KIT MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 312. RUSSIA NGAL ELISA KIT MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 313. RUSSIA NGAL ELISA KIT MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 314. RUSSIA NGAL ELISA KIT MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 315. RUSSIA NGAL ELISA KIT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 316. RUSSIA NGAL ELISA KIT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 317. RUSSIA NGAL ELISA KIT MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 318. RUSSIA NGAL ELISA KIT MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 319. RUSSIA NGAL ELISA KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 320. RUSSIA NGAL ELISA KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 321. RUSSIA NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2018-2024 (USD MILLION)
TABLE 322. RUSSIA NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2025-2030 (USD MILLION)
TABLE 323. RUSSIA NGAL ELISA KIT MARKET SIZE, BY DETECTION METHOD, 2018-2024 (USD MILLION)
TABLE 324. RUSSIA NGAL ELISA KIT MARKET SIZE, BY DETECTION METHOD, 2025-2030 (USD MILLION)
TABLE 325. RUSSIA NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 326. RUSSIA NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 327. RUSSIA NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 328. RUSSIA NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 329. RUSSIA NGAL ELISA KIT MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 330. RUSSIA NGAL ELISA KIT MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 331. ITALY NGAL ELISA KIT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 332. ITALY NGAL ELISA KIT MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 333. ITALY NGAL ELISA KIT MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 334. ITALY NGAL ELISA KIT MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 335. ITALY NGAL ELISA KIT MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 336. ITALY NGAL ELISA KIT MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 337. ITALY NGAL ELISA KIT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 338. ITALY NGAL ELISA KIT MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 339. ITALY NGAL ELISA KIT MARKET SIZE, BY ASSAY TYPE, 2018-2024 (USD MILLION)
TABLE 340. ITALY NGAL ELISA KIT MARKET SIZE, BY ASSAY TYPE, 2025-2030 (USD MILLION)
TABLE 341. ITALY NGAL ELISA KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 342. ITALY NGAL ELISA KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 343. ITALY NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2018-2024 (USD MILLION)
TABLE 344. ITALY NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2025-2030 (USD MILLION)
TABLE 345. ITALY NGAL

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this NGAL ELISA Kit market report include:
  • Thermo Fisher Scientific, Inc.
  • Bio-Techne Corporation
  • Abcam plc
  • BioPorto Diagnostics A/S
  • BioVendor - Laboratorní medicína a.s.
  • RayBiotech, Inc.
  • Sino Biological Inc.
  • Aviva Systems Biology Corporation
  • Boster Biological Technology Co., Ltd.
  • BioVision, Inc.

Related Topics

Related Reports

Human Lipocalin-2/NGAL ELISA Kit Market by End User, Application Area, Sample Type, Kit Format, Reaction Principle, Distribution Channel - Global Forecast 2025-2030 - Product Image

Human Lipocalin-2/NGAL ELISA Kit Market by End User, Application Area, Sample Type, Kit Format, Reaction Principle, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Tumor Marker ELISA Kit Market by Technology (Automated Elisa, Manual Elisa), Product Type (Afp Kit, Ca125 Kit, Ca15-3 Kit), Application, End User - Global Forecast 2025-2030 - Product Image

Tumor Marker ELISA Kit Market by Technology (Automated Elisa, Manual Elisa), Product Type (Afp Kit, Ca125 Kit, Ca15-3 Kit), Application, End User - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Leakage ELISA Kit Market by Product Type (Competitive, Direct, Indirect), Application (Agricultural Testing, Clinical Diagnostics, Environmental Monitoring), End User, Detection Method, Sample Type, Label Enzyme, Automation - Global Forecast 2025-2030 - Product Image

Leakage ELISA Kit Market by Product Type (Competitive, Direct, Indirect), Application (Agricultural Testing, Clinical Diagnostics, Environmental Monitoring), End User, Detection Method, Sample Type, Label Enzyme, Automation - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
TOP2A Cell ELISA Kit Market by End User, Product Type, Application, Species, Distribution Channel - Global Forecast 2025-2030 - Product Image

TOP2A Cell ELISA Kit Market by End User, Product Type, Application, Species, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Progesterone ELISA Test Kits Market by Kit Type, Test Type, Sample Type, Technology, End User, Distribution Channel - Global Forecast to 2030 - Product Image

Progesterone ELISA Test Kits Market by Kit Type, Test Type, Sample Type, Technology, End User, Distribution Channel - Global Forecast to 2030

  • Report
  • 191 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.